The partnership extends the compatibility of Sequel’s Twiist system to allow people with Type 1 diabetes to pair the device ...

A type of device used by more than 500,000 Americans is under scrutiny for a possible life-threatening glitch.

Sequel Med Tech and Senseonics today announced a commercial development agreement to combine insulin delivery and glucose ...

To contact the author of this article, email [email protected] ...

The Iontron eBSF can drive up to 31 miles and then pump approximately 65 cubic yards of concrete without needing a recharge.